Showing results (361-370 of 400) with videos related to
Sort By:
Pageof 40
Cancer Investigation|July 29, 1998
A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanomaB L Gause, W H Sharfman, J E Janik, et al.The Online Journal of Current Clinical Trials|July 1, 1992
Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II StudyM Sznol, R G Steis, J W Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.Cancer Research|September 1, 1995
Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing miceJ L Franco, P Ghosh, R H Wiltrout, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapyD L Longo, E Glatstein, P L Duffey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Dose-related immunologic effects of levamisole in patients with cancerJ Janik, W C Kopp, J W Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II studyA Martin, S Nerenstone, W J Urba, et al.The Journal of Clinical Investigation|November 5, 1998
Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in miceW J Murphy, L A Welniak, D D Taub, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndromeE C Kohn, R G Steis, E A Sausville, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trialD L Longo, E Glatstein, P L Duffey, et al.Pageof 40